<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A15DEEDB-5ADC-4395-A1FD-D7C81690EF3A"><gtr:id>A15DEEDB-5ADC-4395-A1FD-D7C81690EF3A</gtr:id><gtr:name>Graz University</gtr:name><gtr:address><gtr:line1>Graz University</gtr:line1><gtr:line2>Rechbauerstrasse 12</gtr:line2><gtr:postCode>A-8010</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/8C60EACC-2042-4C1A-B611-814952374BA5"><gtr:id>8C60EACC-2042-4C1A-B611-814952374BA5</gtr:id><gtr:name>Faculty of Medicine, Dentistry and Health</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:department>Medicine and Biomedical Science</gtr:department><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A15DEEDB-5ADC-4395-A1FD-D7C81690EF3A"><gtr:id>A15DEEDB-5ADC-4395-A1FD-D7C81690EF3A</gtr:id><gtr:name>Graz University</gtr:name><gtr:address><gtr:line1>Graz University</gtr:line1><gtr:line2>Rechbauerstrasse 12</gtr:line2><gtr:postCode>A-8010</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/8C60EACC-2042-4C1A-B611-814952374BA5"><gtr:id>8C60EACC-2042-4C1A-B611-814952374BA5</gtr:id><gtr:name>Faculty of Medicine, Dentistry and Health</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/16373A12-6246-471D-B513-52AFCD627619"><gtr:id>16373A12-6246-471D-B513-52AFCD627619</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:surname>Sabroe</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/EDB10808-C537-40F5-8043-E4D57C3F0B64"><gtr:id>EDB10808-C537-40F5-8043-E4D57C3F0B64</gtr:id><gtr:firstName>Moira</gtr:firstName><gtr:otherNames>Katherine</gtr:otherNames><gtr:surname>Whyte</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0801983"><gtr:id>C1A6E035-7608-452B-9723-09678ED323BD</gtr:id><gtr:title>The Mechanisms of TLR-Mediated Regulation of Neutrophil Survival</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801983</gtr:grantReference><gtr:abstractText>There is a large group of lung diseases that are both common and hard to treat. Their unifying feature is that they are all caused by the over-activation of a white blood cell called the neutrophil. In general, neutrophils are hugely important. They are very numerous in the blood, and are mobilised very quickly to sites of infection, where they hunt and destroy bacteria, fungi, and some viruses. Their ability to kill bugs comes from carrying a range of toxic proteins which they deliberately release onto the microbes. When the neutrophil?s job is done, it naturally dies and is removed by cells specialised in clearing up (like macrophages). The death of the neutrophil is highly regulated in a process called apoptosis, and is designed so that the neutrophil doesn?t spill any of its toxic antimicrobial compounds into healthy or healing tissues. However, if the neutrophil lives too long, or doesn?t get cleared properly when it dies, spillage of these toxic compounds can cause major tissue damage. This is thought to be an important contributor to a wide range of diseases, for example chronic obstructive pulmonary disease (COPD, commonly caused by smoking). 
We think we?ve worked out how neutrophil survival might be regulated at sites of infection. This survival response depends upon a clever series of orchestrated signals that keep the neutrophil alive for just the right length of time. We also think that, in diseases like COPD, these survival signals are doing too much. Our work plans on studying these systems in much more detail. We want to look at normal neutrophils, and neutrophils taken from the lungs during inflammation. To study these pathways in the test tube, we plan to make neutrophils from stem cells that we have manipulated to be deficient in specific proteins. Putting together these approaches, many of which are really new and technically very exciting, we think we?ll identify some genuinely new potential drug targets that might revolutionise the treatment of lung disease.</gtr:abstractText><gtr:technicalSummary>The neutrophil is our most numerous phagocyte and a principal line of antimicrobial defence, but where activated inappropriately, neutrophilic inflammation is a major cause of airways disease and is very difficult to treat. 
Neutrophils are short-lived cells, whose death by apoptosis allows resolution of inflammation once infection has been removed. We have shown that neutrophil lifespan is extended through activation of a major group of pathogen and damage recognition receptors, the TLRs. At sites of inflammation, infectious stimuli and signals released from damaged tissues activate TLRs to cause a delay in apoptosis that facilitates clearance of infections. 
We have now shown that TLR-mediated neutrophil survival is a two-stage process, regulated by independent signalling pathways. First, direct activation of TLRs on the neutrophil results in transient induction of neutrophil survival. Secondly, activation of TLRs on other cells present at sites of inflammation, such as monocytes, releases survival signals that cause prolonged neutrophil survival. These indirect survival signals act on neutrophil cAMP signalling, and may explain why drugs acting to raise cAMP can fail to control neutrophilic inflammation.
We propose that the handover of regulation of neutrophil survival to external control allows for the withdrawal of survival stimuli and facilitates resolution of injury when danger is passed.
We hypothesise that the targeting of these pathways would restore normal rates of neutrophil apoptosis in inflammatory diseases.
We propose to study, in vitro and in vivo, both components of the regulation of neutrophil survival. First, we will determine how the direct infection signal (mediated by activation of TLR4) is limited in its efficacy, since this may be dysregulated in disease, and represent a new therapeutic target. Secondly, we will use a combination of microarray and proteomic approaches to determine how cAMP-mediated signalling causes neutrophil survival. We will challenge human subjects with inhaled endotoxin, and explore in vivo how these direct and indirect survival signals contribute to the regulation of neutrophilic airway inflammation. Neutrophils are hard to genetically modify, so when we identify new targets involved in the regulation of these survival pathways, we will knock down their function in neutrophils derived from bone marrow and embryonic stem cells, using methodology established in our groups. These studies will identify new pathways, and hence therapeutic targets, regulating neutrophil apoptosis in man, and target their function using novel approaches to the study of neutrophil biology.</gtr:technicalSummary><gtr:fund><gtr:end>2013-03-29</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>712005</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Respiratory Development Planning Unit DPU</gtr:department><gtr:description>GSK collaboration for access to compounds</gtr:description><gtr:id>30CCD053-CD50-4E32-9DC4-E037F15CE043</gtr:id><gtr:impact>Publication in preparation</gtr:impact><gtr:partnerContribution>Provision of reagents and intellectual contribution</gtr:partnerContribution><gtr:piContribution>Discussed data regarding mechanisms of neutrophil apoptosis</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Graz</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:department>Pharmacology</gtr:department><gtr:description>University of Graz</gtr:description><gtr:id>5A57B99C-9A34-491B-8587-A04914DF93B8</gtr:id><gtr:impact>None as yet, expecting to contribute to next manuscript</gtr:impact><gtr:partnerContribution>Advice regarding antibodies and compounds, provision of collaborative data</gtr:partnerContribution><gtr:piContribution>Collaborative exploration of prostaglandin receptor expression and function in neutrophils</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>COPD MAP</gtr:description><gtr:id>13680A4E-6DC9-4FB4-AD49-EAE9DB526BD7</gtr:id><gtr:impact>Funding but no publication outputs as yet; new collaboration</gtr:impact><gtr:partnerContribution>Access to additional patient samples and tool compounds from Industry</gtr:partnerContribution><gtr:piContribution>Expertise in neutrophil biology and pathogenesis of inflammation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Faculty of Medicine, Dentistry and Health</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Infection and Immunity</gtr:department><gtr:description>Zebrafish</gtr:description><gtr:id>A6AACCE4-5460-40E8-9E99-0217D44E8067</gtr:id><gtr:impact>Data to contribute to next manuscript</gtr:impact><gtr:partnerContribution>Set up zebrafish models of key neutrophil regulatory pathways identified by our research</gtr:partnerContribution><gtr:piContribution>Shared knowledge re PKA biology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biological Sciences Liverpool</gtr:department><gtr:description>Collaboration for bioinformatic approaches</gtr:description><gtr:id>289CF4F6-DDD2-4B24-9526-5797FC35CF04</gtr:id><gtr:impact>Publications currently in preparation</gtr:impact><gtr:partnerContribution>Provided analysis techniques resulting in new hypothesis development</gtr:partnerContribution><gtr:piContribution>Developed detailed collaboration to facilitate bioinformatic approach to neutrophil apoptosis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Talks at International Meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>B2E66287-3AA0-4F85-92AB-078CE8782C49</gtr:id><gtr:impact>'Targeting TLRs'. New Drugs for Asthma and COPD, Brompton Hospital 2008. 'The networks that regulate innate and adaptive immunity in asthma and COPD'. Invited talk for the joint BTS/BALR symposium at the British Thoracic Society Winter meeting, London 2007. 8th Annual Lund COPD Symposium April 2007 talk title 'Integration of the innate and adaptive immune responses in COPD'. Chair of Session and speaker at British Society for Allergy and Clinical Immunology, July 2007. Talk title 'Inflammatory Networks of Asthma' 'Toll-like receptors:&amp;nbsp; Potential therapeutic aspects'. Joint British Thoracic Society/ British Society for Allergy and Clinical Immunology, BTS Winter meeting, Dec 2006

Generated useful collaborations and raised importance of field</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2006,2007,2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>3195A2F7-0A98-479D-9DEF-E335CA33BA72</gtr:id><gtr:impact>Talked to 60 primary school children about lung science and health

Asked for repeat visit each year</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Asthma and airway inflammation national science week presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>DE3EC623-78FC-4C24-A127-7CFA5361A201</gtr:id><gtr:impact>Spoke to a whole year group (approx 120 children) of late teenage on the biology of asthma, took members of research group to explain science, generated interest in pathobiology of asthma

None specific</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Primitive Streak</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>0B05C169-713F-48ED-A2A4-FA4048AFE61A</gtr:id><gtr:impact>The Primitive Streak Exhibition (Helen Storey Foundation) was used as a vehicle for a national science week public lecture with demonstrations related to the lung. There were also opportunities in the central Winter Gardens in Sheffield for the public to have their spirometry measured and understand more about how the lungs work. A series of special dresses were created by Helen Storey to illustrate the function of the lung, as part of her longstanding interest in using new techniques to explain human biology.

Local and national press activity</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit through National Science Week</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>3A8AB53E-5654-45CD-9A3B-A9316CE0C71B</gtr:id><gtr:impact>We attended a local primary school, and engaged in workshops with the whole year group (about 80 pupils) to explain how airway inflammation works.

We have been asked to do this again, received excellent feedback</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>National Science Week School visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>A55981D3-263A-43C7-B083-6AE3CC664FE2</gtr:id><gtr:impact>Approx 120 students aged 14-16 attended a talk on airways inflammation and asthma, given by me and my group (including LCP who was funded by this fellowship).

Generated interest by school children in asthma and inflammation</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Heart Research UK Fellowship</gtr:description><gtr:end>2014-02-02</gtr:end><gtr:fundingOrg>Heart Research UK</gtr:fundingOrg><gtr:id>D11A13CC-15A7-4FDD-857F-70C6066D5F68</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC ABPI COPD initiative</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>09ED30AA-FE52-4E4E-96C9-7BB1D6E73005</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>35000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC PhD studentship</gtr:description><gtr:end>2015-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>B2099A9C-8983-423E-8395-F9D66B110EB4</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>National Institute for Health Research (NIHR)</gtr:department><gtr:description>NIHR Fellowship</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>University College London Hospitals Charity (UCLH)</gtr:fundingOrg><gtr:id>950848A0-2E83-494D-84FB-7A6930C3AF04</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4B183C10-BEBF-4538-99B7-F31E77AD2FB9"><gtr:id>4B183C10-BEBF-4538-99B7-F31E77AD2FB9</gtr:id><gtr:title>Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/35319da115a6ef0296e74a6594e5b7f5"><gtr:id>35319da115a6ef0296e74a6594e5b7f5</gtr:id><gtr:otherNames>Walmsley SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/973D85D6-2C0C-434A-8CE8-AFAC518F014E"><gtr:id>973D85D6-2C0C-434A-8CE8-AFAC518F014E</gtr:id><gtr:title>NR4A orphan nuclear receptor family members, NR4A2 and NR4A3, regulate neutrophil number and survival.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/701f833924554817b65818c42b70aa53"><gtr:id>701f833924554817b65818c42b70aa53</gtr:id><gtr:otherNames>Prince LR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D03F3971-CB25-4D21-9984-2C3F0F8CC7BD"><gtr:id>D03F3971-CB25-4D21-9984-2C3F0F8CC7BD</gtr:id><gtr:title>Interleukin-1? regulates CXCL8 release and influences disease outcome in response to Streptococcus pneumoniae, defining intercellular cooperation between pulmonary epithelial cells and macrophages.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2069e63add5b275198794c2f63a0d84c"><gtr:id>2069e63add5b275198794c2f63a0d84c</gtr:id><gtr:otherNames>Marriott HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8FAAB2C0-4A0D-4655-8A62-138796F24E58"><gtr:id>8FAAB2C0-4A0D-4655-8A62-138796F24E58</gtr:id><gtr:title>The role of TLRs in neutrophil activation.</gtr:title><gtr:parentPublicationTitle>Current opinion in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/701f833924554817b65818c42b70aa53"><gtr:id>701f833924554817b65818c42b70aa53</gtr:id><gtr:otherNames>Prince LR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-4892</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801983</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>